Worldwide prevention of vertical human immunodeficiency virus (HIV) transmission

Obstetrical and Gynecological Survey

Volumn 52, Issue 5, 1997, Pages 301-309

  Van Vliet, A ^a   Van Roosmalen, J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOL; ZIDOVUDINE;

CESAREAN SECTION; CLEANING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MALARIA; REVIEW; SYPHILIS; TREATMENT PLANNING; VAGINA; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

BREAST FEEDING; DEVELOPED COUNTRIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; PREGNANCY; RISK FACTORS; WORLD HEALTH;

EID: 0030946118     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199705000-00022     Document Type: Review

References (87)

1. Goeman J, Piot P. HIV infection and AIDS in the tropics. Med J Aust 1993;159:549-551.
2. Quinn TC, Ruff A, Halsey N. Pediatric acquired immunodeficiency syndrome: Special considerations for developing nations. Pediatr Infect Dis J 1992;11:558-568.
3. Henrion R, Henrion-Geant E, Mandelbrot L et al. Trends in HIV transmission in pregnancy [letter]. Lancet 1990;335:1401.
4. Dinsmoor MJ. HIV infection and pregnancy. Clin Perinatol 1994;21:85-94.
5. Coll O, Torné A, Ercilla G et al. Temporal trend of HIV infection among pregnant women in a reference hospital in Barcelona. AIDS 1993;7:443-444.
6. Chin J. Current and future dimension of the HIV/AIDS pandemic in women and children. Lancet 1991;336:221-224.
7. Chew CB, Downie JC, Cunningham AL. Unlinked anonymous screening of antenatal patients for antibody to human immunodeficiency virus type 1 (HIV-1). Med J Aust 1994;160:693-696.
8. Gwinn M, Pappaioanou M, George JR et al. Prevalence of HIV infection in childbearing women in the United States - Surveillance using newborn blood samples. J Am Med Assoc 1991;265:1704-1708.
9. Bindels PJE, Mulder-Folkerts DKF, Schutte MF et al. Prevalentie van HIV-antistoffen bij zwangere vrouwen in het Amsterdamse HIV-peilstationonderzoek, 1988-1993. Ned Tijdschr Geneeskd 1995;139:994-997.
10. Harry TO, Bukbuk DN, Idrisa A et al. HIV infection among pregnant women: A worsening situation in Maiduguri, Nigeria. Trap Geogr Med 1994;46:46-47.
11. Allen S, Lindan C, Serufilira A et al. Human immunodeficiency virus infection in urban Rwanda: Demographic and behavioral correlates in a representative sample of childbearing women. J Am Med Assoc 1991;266:1657-1663.
12. Barreto J, Liljestrand J, Palha de Sousa C et al. HIV-1 and HIV-2 antibodies in pregnant women in the city of Maputo, Mozambique. A comparative study between 1982/1983 and 1990. Scand J Infect Dis 1993;25:685-688.
13. Green SDR, Cutting WAM, Mokili JLK et al. Stable seroprevalence of HIV-1 in antenatal women in rural Bas-Zaïre, 1988-1993. AIDS 1994;8:397-398.
14. Batter V, Matela B, Nsuami M et al. High HIV-1 incidence in young women masked by stable overall seroprevalence among childbearing women in Kinshasa, Zaïre: estimating incidence from serial seroprevalence data. AIDS 1994;8:811-815.
15. Jirapinyo M, Petchclai B, Phiromsawat S. Prevalence of positive anti-HIV in pregnant women at Ramathibodi Hospital. J Med Assoc Thai 1991;74:653-657.
16. European Collaborative Study. Children born to women with HIV-1 infection: Natural history and risk of transmission. Lancet 1991;337:253-260.
17. Gabiano C, Tovo P-A, de Martino M et al. Mother-to-child transmission of human immunodeficiency virus type 1: Risk of infection and correlates of transmission. Pediatrics 1992;90: 369-374.
18. Blanche S, Rouzioux C, Moscato M-LG et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-1648.
19. Ryder RW, Nsa W, Hassig SE et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaïre. N Engl J Med 1989;320:1637-1642.
20. Hira SK, Kamanga J, Bhat GJ et al. Perinatal transmission of HIV-1 in Zambia. Br Med J 1989;299:1250-1252.
21. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 1995;9:721-726.
22. Andreasson P-A, Dias F, Nauclér A et al. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS 1993;7:989-993.
23. Sibailly TS, Adjorlolo G, Gayle H, Ekpini E et al. Prospective study to compare HIV-1 and HIV-2 perinatal transmission in Abidjan, Cote d'Ivoire. VIIIth International Conference on AIDS (Amsterdam) 1992; Book 1:WeC 1065 (Abstr).
24. Report of a consensus workshop, Siena, Italy, January 17-18, 1992. Maternal factors involved in mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 1992;5:1019-1029.
25. St. Louis ME, Kamenga M, Brown C et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. J Am Med Assoc 1993;269:2853-2859.
26. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-1012.
27. Goedert JJ, Mendez H, Drummond JE et al. Mother-to-infant transmission of human immunodeficiency virus type 1: Association with prematurity or low anti-gp120. Lancet 1989;2: 1351-1354.
28. Dunn DT, Newell ML, Ades AE et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340:585-588.
29. European Collaborative Study. Cesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994;343: 1464-1467.
30. Villari P, Spino C, Chalmers TC et al. Cesarean section to reduce perinatal transmission of human immunodeficiency virus. Online J Curr Clin Trials 1993;2: Doc No 74.
31. Goedert JJ, Duliège A-M, Amos CI et al. High risk of HIV-1 infection for first-born twins. Lancet 1991;338:1471-1475.
32. Devash Y, Calvelli TA, Wood DG et al. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci USA 1990;87: 3445-3449.
33. Rossi P, Moschese V, Broliden PA et al. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers. Proc Natl Acad Sci USA 1989;86:8055-8058.
34. Scarlatti G, Albert J, Rossi P et al. Mother-to-child transmission of human immunodeficiency virus type 1: Correlation with neutralizing antibodies against primary isolates. J Infect Dis 1993;168:207-210.
35. Boer K, Mulder-Kampinga GA, Scherpbier HJ. HIV en zwangerschap. Ned Tijdschr Geneeskd 1995;139:970-975.
36. Burgard M, Mayaux M-J, Blanche S et al. The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. N Engl J Med 1992;327: 1192-1197.
37. Krivine A, Firtion G, Cao L et al. HIV replication during the first weeks of life. Lancet 1992;339:1187-1189.
38. Backé E, Unger M, Jimenez E et al. Fetal organs infected by HIV-1. AIDS 1993;7:896-897.
39. Soeiro R, Rubinstein A, Rashbaum WK et al. Maternofetal transmission of AIDS: Frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA. J Infect Dis 1992;166:699-703.
40. Sprecher S, Soumenkoff G, Puissant F et al. Vertical transmission of HIV in 15-week fetus. Lancet 1986;2:288-289.
41. Mano H, Chermann J-C. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retrov 1991;7:83-88.
42. Borkowsky W, Krasinski K, Pollack H et al. Early diagnosis of human immunodeficiency virus infection in children <6 months of age: Comparison of polymerase chain reaction, culture, and plasma antigen capture techniques. J Infect Dis 1992;166:616-619.
43. Douglas GC, King BF. Maternal-fetal transmission of human immunodeficiency virus: A review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992;15:678-691.
44. Chandwani S, Greco MA, Mittal K et al. Pathology and human immunodeficiency virus expression in placentas of seropositive women. J Infect Dis 1991;163:1134-1138.
45. Lewis SH, Reynolds-Kohler C, Fox HE et al. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in 8-week fetuses. Lancet 1990;335:565-568.
46. Zachar V, Norskov-Lauritsen N, Juhl C et al. Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. J Gen Virol 1991;72:1253-1260.
47. Amirhessami-Aghili N, Spector SA. Human immunodeficiency virus type 1 infection of human placenta: Potential route for fetal infection. J Virol 1991;65:2231-2236.
48. Maury W, Potts BJ, Rabson AB. HIV-1 infection of first-trimester and term human placental tissue: A possible mode of maternal-fetal transmission. J Infect Dis 1989;160:583-588.
49. Phillips DM, Tan X. HIV-1 infection of the trophoblast cell line BeWo: A study of virus uptake. AIDS Res Human Retrov 1992;8:1683-1691.
50. Mattern CFT, Murray K, Jensen A. Localization of human immunodeficiency virus core antigen in term human placentas. Pediatrics 1992;89:207-209.
51. Jauniaux E, Nessmann C, Imbert MC et al. Morphological aspects of the placenta in HIV pregnancies. Placenta 1988;9: 633-642.
52. Pollack H, Borkowsky W, Krasinski K. Maternal syphilis is associated with enhanced perinatal transmission. 30th Interscience Conference on Antimicrobial Agents and Chemotherapy (Atlanta) 1990;1274A (Abstr).
53. Pollack MS, Kirkpatrick D, Kapoor N et al. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982;307:662-666.
54. Mundy DC, Schinazi RF, Gerber AR et al. Human immunodeficiency virus isolated from amniotic fluid. Lancet 1987;2:459-460.
55. Duliège A, Amos CI, Felton S et al. HIV-1 infection rate and progression of disease in 1st and 2nd-born twins born to HIV-infected mothers hypothesis regarding in-utero and perinatal exposures. IXth Internat Conference on AIDS (Berlin) 1993; Book 1: WS-C10-4 (Abstr).
56. Towers CV, Deveikis A, Asrat T et al. Role of "bloodless C section" to decrease maternal child HIV transmission. A pilot study. IXth International Conference on AIDS (Berlin) 1993; PO-C16-2978 (Abstr).
57. Amstey MS, Monif GRG. Genital herpesvirus infection in pregnancy. Obstet Gynecol 1974;44:394-397.
58. Vogt M, Witt DJ, Craven DE et al. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1986;1:525-527.
59. Hénin Y, Mandelbrot L, Henrion R et al. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr 1993;6:72-75.
60. Ziegler JB, Cooper DA, Johnson RO et al. Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1985;1:896-897.
61. van de Perre P, Simonon A, Msellati P et al. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1991;325:593-598.
62. van de Perre P, Simonon A, Hitimana D-G et al. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 1993;341:914-918.
63. Thiry L, Sprecher-Goldberger S, Jonckheer T et al. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 1985;2:891-892.
64. Johnstone FD, Brettle RP, MacCallum LR et al. Women's knowledge of their HIV antibody state: Its effect on their decision whether to continue the pregnancy. Br Med J 1990; 300:23-24.
65. Bindels PJE. Resultaten van de screening op HIV-antistoffen bij zwangere vrouwen, bezoeksters van infertiliteitspoliklinieken en abortusklinieken in de regio Amsterdam in 1990. Ned Tijdschr Geneeskd 1991;135:2123-2128.
66. Mulder-Kampinga GA, Boer K, Scherpbier HJ. HIV-infectie bij zwangere vrouwen in Nederland. Ned Tijdschr Geneeskd 1992;136:80-84.
67. Lallemant M, Lallemant-Le Coeur S, Cheynier D et al. Characteristics associated with HIV-1 infection in pregnant women in Brazzaville, Congo. J Acquir Immune Defic Syndr 1992;5: 279-285.
68. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180.
69. CDC. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR 1994;43:285-287.
70. Mofenson L, Balsley J, Simonds RJ et al. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994;43(RR-11):1-20.
71. Boyer PJ, Dillon M, Navaie M et al. Factors predictive of maternal-fetal transmission of HIV-1. J Am Med Assoc 1994; 271:1925-1930.
72. Masquelier B, Lemoigne E, Pellegrin I et al. Letter to the editor. N Engl J Med 1993;329:1123-1124.
73. Siegrist C-A, Yerly S, Kaiser L et al. Mother to child transmission of zidovudine-resistant HIV-1. Lancet 1994;344:1771-1772.
74. Birth outcomes following zidovudine therapy in pregnant women. MMWR 1994;43:409, 415-416.
75. Semba RD, Miotti PG, Chiphangwi JD et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593-1597.
76. Bridbord K, Willoughby A. Vitamin A and mother-to-child HIV-1 transmission. Lancet 1994;343:1585-1586.
77. Rothman KJ, Moore LL, Singer MR et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-1373.
78. Oakley GP, Erickson JD. Vitamin A and birth defects. Continuing caution is needed. N Engl J Med 1995;333:1414-1415.
79. Newell M-L, Peckham CS. Working towards a European strategy for intervention to reduce vertical transmission of HIV. Br J Obstet Gynaecol 1994;101:192-196.
80. Biggar RJ, Miotti PG, Taha TE et al. Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996;347:1647-1650.
81. Nair P, Alger L, Hines S et al. Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J Acquir Immune Defic Syndr 1993;6:298-302.
82. de Muylder X. Cesarean sections in developing countries: Some considerations. Health Pol Plann 1993;8:101-112.
83. van Roosmalen J. Safe motherhood: Cesarean section or symphysiotomy? Am J Obstet Gynecol 1990;163:1-4.
84. van Roosmalen J, van der Does CD. Cesarean birth rates worldwide. Trop Geogr Med 1995;47:9-22.
85. Fuith LC, Czarnecki M, Wachter H et al. Mode of delivery in HIV-1-infected women. Lancet 1992;390:1603.
86. Balaji LN. Women and AIDS. J Indian Med Assoc 1994;92:15-16, 38.
87. Ziegler JB. Breast-feeding and HIV. Lancet 1993;342:1437-1438.